Compare Stocks: ARAY, APYX, KEQU, and MBOT

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
APYX Apyx Medical	$3.12 +3.0%	$3.98	$1.70 ▼ $5.08	$131.43M	1.39	121,805 shs	52,891 shs
ARAY Accuray	$0.28 -3.9%	$0.28	$0.22 ▼ $2.10	$33.43M	1.39	1.46 million shs	462,471 shs
KEQU Kewaunee Scientific	$37.07 +1.6%	$36.53	$33.27 ▼ $60.89	$106.34M	0.72	2,829 shs	5,360 shs
MBOT Microbot Medical	$1.50 +0.7%	$1.78	$1.44 ▼ $4.67	$100.75M	1.06	768,947 shs	330,720 shs

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
APYX Apyx Medical	0.00%	+2.97%	-18.54%	-24.46%	+53.69%
ARAY Accuray	0.00%	+1.01%	+17.97%	-8.44%	-81.39%
KEQU Kewaunee Scientific	0.00%	+1.53%	+2.01%	-7.26%	-34.95%
MBOT Microbot Medical	0.00%	-3.23%	-14.77%	-12.28%	-54.68%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
APYX Apyx Medical	$3.12 +3.0%	$3.98	$1.70 ▼ $5.08	$131.43M	1.39	121,805 shs	52,891 shs
ARAY Accuray	$0.28 -3.9%	$0.28	$0.22 ▼ $2.10	$33.43M	1.39	1.46 million shs	462,471 shs
KEQU Kewaunee Scientific	$37.07 +1.6%	$36.53	$33.27 ▼ $60.89	$106.34M	0.72	2,829 shs	5,360 shs
MBOT Microbot Medical	$1.50 +0.7%	$1.78	$1.44 ▼ $4.67	$100.75M	1.06	768,947 shs	330,720 shs

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
APYX Apyx Medical	0.00%	+2.97%	-18.54%	-24.46%	+53.69%
ARAY Accuray	0.00%	+1.01%	+17.97%	-8.44%	-81.39%
KEQU Kewaunee Scientific	0.00%	+1.53%	+2.01%	-7.26%	-34.95%
MBOT Microbot Medical	0.00%	-3.23%	-14.77%	-12.28%	-54.68%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
APYX Apyx Medical	2.71	Moderate Buy	$6.60	111.54% Upside
ARAY Accuray	1.67	Reduce	$2.00	611.74% Upside
KEQU Kewaunee Scientific	2.00	Hold	N/A	N/A
MBOT Microbot Medical	2.40	Hold	$6.38	325.00% Upside

Current Analyst Ratings Breakdown

Latest ARAY, APYX, KEQU, and MBOT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/20/2026	MBOT Microbot Medical	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
8/19/2026	MBOT Microbot Medical	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
8/14/2026	MBOT Microbot Medical	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$5.00 ➝ $4.00
8/4/2026	ARAY Accuray	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
7/22/2026	MBOT Microbot Medical	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
7/14/2026	MBOT Microbot Medical	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
7/14/2026	APYX Apyx Medical	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold
7/13/2026	APYX Apyx Medical	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$7.00
7/8/2026	MBOT Microbot Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
7/8/2026	ARAY Accuray	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Neutral
6/30/2026	KEQU Kewaunee Scientific	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold (C)

(Data available from 8/23/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
APYX Apyx Medical	$52.84M	2.49	N/A	N/A	$0.26 per share	12.00
ARAY Accuray	$401.95M	0.08	$0.04 per share	6.30	$0.72 per share	0.39
KEQU Kewaunee Scientific	$282M	0.38	$5.96 per share	6.22	$26.80 per share	1.38
MBOT Microbot Medical	N/A	N/A	N/A	N/A	$1.03 per share	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
APYX Apyx Medical	-$11.21M	-$0.20	N/A	N/A	N/A	-14.78%	-76.60%	-13.91%	11/5/2026 (Estimated)
ARAY Accuray	-$1.59M	-$0.40	N/A	N/A	N/A	-12.24%	-92.88%	-10.78%	11/4/2026 (Estimated)
KEQU Kewaunee Scientific	$9.62M	$3.22	11.51	N/A	N/A	3.41%	14.10%	5.55%	9/16/2026 (Estimated)
MBOT Microbot Medical	-$13.14M	-$0.24	N/A	N/A	N/A	N/A	-21.87%	-20.76%	11/11/2026 (Estimated)

Latest ARAY, APYX, KEQU, and MBOT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/19/2026	Q4 2026	ARAY Accuray	-$0.03	-$0.02	+$0.01	-$0.02	$105.30 million	$100.92 million
8/11/2026	Q2 2026	MBOT Microbot Medical	-$0.0767	-$0.08	-$0.0033	-$0.08	$0.13 million	$0.24 million
8/6/2026	Q2 2026	APYX Apyx Medical	-$0.0820	-$0.07	+$0.0120	-$0.07	$13.18 million	$13.88 million
6/23/2026	Q4 2026	KEQU Kewaunee Scientific	N/A	$1.14	N/A	$1.13	N/A	$71.40 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
APYX Apyx Medical	N/A	N/A	N/A	N/A	N/A
ARAY Accuray	N/A	N/A	N/A	N/A	N/A
KEQU Kewaunee Scientific	N/A	N/A	N/A	N/A	N/A
MBOT Microbot Medical	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
APYX Apyx Medical	3.19	5.68	4.53
ARAY Accuray	3.21	1.42	0.66
KEQU Kewaunee Scientific	0.53	2.18	1.55
MBOT Microbot Medical	N/A	18.56	17.82

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
APYX Apyx Medical	55.33%
ARAY Accuray	64.08%
KEQU Kewaunee Scientific	32.69%
MBOT Microbot Medical	16.30%

Insider Ownership

Company	Insider Ownership
APYX Apyx Medical	15.90%
ARAY Accuray	4.36%
KEQU Kewaunee Scientific	14.10%
MBOT Microbot Medical	4.74%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
APYX Apyx Medical	270	42.12 million	35.43 million	Optionable
ARAY Accuray	1,040	118.96 million	113.78 million	Optionable
KEQU Kewaunee Scientific	1,231	2.87 million	2.46 million	Not Optionable
MBOT Microbot Medical	20	67.17 million	63.98 million	Optionable

ARAY, APYX, KEQU, and MBOT Headlines

Recent News About These Companies

HC Wainwright Cuts Earnings Estimates for Microbot Medical

August 23 at 1:13 AM | americanbankingnews.com

Microbot Medical (NASDAQ:MBOT) Lowered to "Hold" Rating by Zacks Research

August 22 at 6:29 AM | marketbeat.com

HC Wainwright Lowers Earnings Estimates for Microbot Medical

August 21 at 7:42 AM | marketbeat.com

Microbot Medical's (MBOT) "Buy" Rating Reiterated at B. Riley Financial

August 17, 2026 | americanbankingnews.com

B. Riley Financial Reaffirms "Buy" Rating for Microbot Medical (NASDAQ:MBOT)

August 14, 2026 | marketbeat.com

Microbot Medical Inc.: Microbot Medical Files 10-Q, Reports Significant Revenue and Customer Growth During the 2026 Second Quarter

August 11, 2026 | finanznachrichten.de

Microbot Medical® Files 10-Q, Reports Significant Revenue and Customer Growth During the 2026 Second Quarter

August 11, 2026 | markets.businessinsider.com

Microbot Medical Inc. (MBOT) Reports Q2 Loss, Lags Revenue Estimates

August 11, 2026 | zacks.com

Microbot Medical (NASDAQ:MBOT) Issues Earnings Results

August 11, 2026 | marketbeat.com

Microbot Medical (MBOT) Expected to Announce Quarterly Earnings on Tuesday

August 4, 2026 | marketbeat.com

Microbot Medical Inc. (NASDAQ:MBOT) Given Consensus Rating of "Buy" by Brokerages

August 4, 2026 | marketbeat.com

Microbot Medical (NASDAQ:MBOT) Rating Increased to Strong-Buy at Zacks Research

July 24, 2026 | marketbeat.com

New Strong Buy Stocks for July 23rd

July 23, 2026 | zacks.com

Microbot Medical to Present on Endovascular Robotics at Society of Robotic Surgery Annual Meeting

July 21, 2026 | quiverquant.comQ

Microbot Medical® Among Featured Companies Showcasing Novel Robotic Technologies and Digital Surgery Applications at the Society of Robotic Surgery Annual Meeting

July 21, 2026 | globenewswire.com

Microbot Medical® Reports Over 100% Revenue and Customer Growth as Procedure Volume Also Rises in the Second Quarter of 2026

July 7, 2026 | globenewswire.com

Microbot Medical® Increases Manufacturing Capacity as Demand for the LIBERTY® System Rises; Enters into Strategic Agreement with Sanmina, a Global Manufacturing Leader

June 30, 2026 | globenewswire.com

Microbot Medical® Wins Surgical Robotics Industry Award for the LIBERTY® Endovascular Robotic System

June 25, 2026 | globenewswire.com

Microbot Medical® Announces First Health System in Pennsylvania to Adopt the LIBERTY® Endovascular Robotic System

June 23, 2026 | globenewswire.com

Microbot Medical Expands Federal Access for LIBERTY Robotics

June 17, 2026 | theglobeandmail.com

Microbot Medical® Enters Into an Agreement to Expand Access for America’s Veteran and Military Patient Populations

June 16, 2026 | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

ARAY, APYX, KEQU, and MBOT Company Descriptions

Apyx Medical NASDAQ:APYX

$3.12 +0.09 (+2.97%)

As of 08/21/2026 04:00 PM Eastern

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Accuray NASDAQ:ARAY

$0.28 -0.01 (-3.90%)

As of 08/21/2026 04:00 PM Eastern

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.

Kewaunee Scientific NASDAQ:KEQU

$37.07 +0.60 (+1.65%)

As of 08/21/2026 04:00 PM Eastern

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The company's laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; and technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture. It sells its products primarily through dealers, its subidiaries, and a national distributor. The company was founded in 1906 and is headquartered in Statesville, North Carolina.

Microbot Medical NASDAQ:MBOT

$1.50 +0.01 (+0.67%)

As of 08/21/2026 04:00 PM Eastern

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ARAY, APYX, KEQU, and MBOT Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ARAY, APYX, KEQU, and MBOT Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ARAY, APYX, KEQU, and MBOT Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

ARAY, APYX, KEQU, and MBOT Company Descriptions

Apyx Medical NASDAQ:APYX

Accuray NASDAQ:ARAY

Kewaunee Scientific NASDAQ:KEQU

Microbot Medical NASDAQ:MBOT

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ARAY, APYX, KEQU, and MBOT Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ARAY, APYX, KEQU, and MBOT Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ARAY, APYX, KEQU, and MBOT Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

ARAY, APYX, KEQU, and MBOT Company Descriptions

Apyx Medical NASDAQ:APYX

Accuray NASDAQ:ARAY

Kewaunee Scientific NASDAQ:KEQU

Microbot Medical NASDAQ:MBOT

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools